Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA
Cell-free DNA (cfDNA) methylation has emerged as a promising biomarker for early cancer detection, tumor type classification, and treatment response monitoring. Enrichment-based cfDNA methylation profiling methods such as cfMeDIP-seq have shown high accuracy in the classification of multiple cancer...
Guardado en:
Autores principales: | Jinyong Huang, Alex C. Soupir, Brian D. Schlick, Mingxiang Teng, Ibrahim H. Sahin, Jennifer B. Permuth, Erin M. Siegel, Brandon J. Manley, Bruna Pellini, Liang Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d84a411f7d044d29bb98cbdc6bef09b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
por: Verena Lieb, et al.
Publicado: (2021) -
Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
por: Kate I. Glennon, et al.
Publicado: (2021) -
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
por: Martin Metzenmacher, et al.
Publicado: (2022) -
Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction
por: Graziano Santoro, et al.
Publicado: (2021) -
Prenatal Stress Caused by Movement Restriction Induces Changes in the Development of Skull Bone in CF-1 Mice Progeny
por: Henríquez,Ricardo, et al.
Publicado: (2013)